Gene clues may predict preeclampsia in egg donor pregnancies
NCT ID NCT07178652
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study looks at how certain gene combinations (HLA-C and KIR) might affect the risk of preeclampsia in pregnancies from egg donation. Researchers will collect cheek swabs from mothers, children, and egg donors to analyze DNA. By comparing gene patterns between those who developed preeclampsia and those who did not, they hope to uncover immune-related risk factors. The goal is to improve screening and care for future pregnancies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help identify women at higher risk for preeclampsia after egg donation, leading to better monitoring and prevention strategies.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly prevent or cure preeclampsia, and results may not apply to all populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OOCYTE DONATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Pregnancy study seeks links between insulin resistance and placental problems
- Blood test could spot hidden heart damage in preeclampsia
- Pregnancy warning sign may flag heart risk in type 1 diabetes
- Egg donation pregnancy study seeks clues to dangerous blood pressure disorder
- Aspirin metabolism may hold key to preventing preeclampsia